Comparative analysis of absorption resonances between carbynes and cyclo[n]carbons.

Two approaches are presented here to analyze the absorption resonances between carbynes and cyclo[n]carbons, namely the analytical tight-binding model to calculate the optical selection rules of cumulenic atomic rings and chains and theab initiotime-dependent density functional theory for the optical investigation of polyynic carbon ring and chains. The optical absorption spectra of the carbon ring match that of the finite chain when their eigen energies align following theNring=2Nchain+2rule, which states that the number of atoms in an atomic ringNringis twice the number of atoms on a finite chainNchainwith two additional atoms. Two representative atomic chains are chosen for our numerical calculations, specifically carbynes withN=7and8carbon atoms as optical resonance spectra match to a recently synthesized carbon ring called cyclo[18]carbon. Despite the mismatch in resonance peaks, molecular orbital transitions of both carbynesN = 7 and 8 and cyclo[18]carbon reveal a wave function symmetry change from inversion to reflection and vice versa for allowed molecular orbital transitions, which results in electron density redistribution along the polyynic carbyne axis or the cyclo[18]carbon circumference. Our investigation of the correlation of optical absorption peaks between carbynes and cyclo[n]carbons is a step towards enhancing the reliability of allotrope identification in advanced molecular device spectroscopy. Moreover, this work could facilitate the non-invasive, rapid and crucial assessment of these sensitive 1D allotropes by providing accurate descriptions of their electronic and optical properties, particularly in controlled synthesis environments.

Effect of the isotiazole adjuvants in combination with cisplatin in chemotherapy of neuroepithelial tumors: experimental results and modeling.

Chemotherapy is one of the main treatment options for cancer, but it is usually accompanied with negative side effects. The classical drugs combination with synergistic adjuvants can be the solution to this problem, allowing reducing therapeutic dose. Elucidating the mechanism of adjuvant action is of key importance for the selection of the optimal agent. Here we examine the system drug-adjuvant to explain the observed effect in practice. We used the first line drug cisplatin. Morpholinium and 4-methylpiperazinium 4,5-dichloro isothiazol-3-carboxylates were selected as adjuvants. The study of the cisplatin-adjuvant system was carried out by quantum chemical modeling using DFT. It turned out that adjuvants form conjugates with cisplatin that lead to the relocation of frontier molecular orbitals as well as increase of conjugate's dipole moment. It resulted in change of the interaction character with DNA and increase of the bioactivity of the system. The data obtained are the basis for expanding the studies to include other drugs and adjuvants. Oncologists will have opportunity to use "classical" chemotherapy drugs in combination with synergists for those patients who have not been previously recommended to such a treatment because of pronounced toxic side effects.